The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Major dietary sources of energy (fat, carbohydrates, protein, alcohol) and breast cancer (BC) survival: evidence for favorable levels of intake.

Print

Sub-category:
Adjuvant Therapy

Category:
Breast Cancer

Meeting:
2002 ASCO Annual Meeting

Session Type and Session Title:
Poster Discussion, Breast Cancer

Abstract No:
178

Citation:
Proc Am Soc Clin Oncol 21: 2002 (abstr 178)

Author(s):
Pamela J Goodwin, Marguerite Ennis, Hood Nicky, Kathleen I Pritchard, Maureen E Trudeau, Jarley Koo, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada; Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, ON, Canada; Toronto-Sunnybrook Regional Cancer Center, University of Toronto, Toronto, ON, Canada; St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Abstract:

Diet, particularly fat intake, has been postulated to influence BC prognosis but existing evidence is weak and inconsistent. In a prospective cohort study we confirmed a previously reported curvilinear association of BMI with overall survival (OS) (ASCO 2000 Abstract 272), the best OS occurring when BMI was 20-25 kg/m2. We now seek evidence of similar curvilinear (quadratic) associations of major energy sources with OS. METHODS: 477 women with surgically resected T1-3, N0-1, M0 BC completed the Block Food Frequency Questionnaire 65.3¦32.5 days post-diagnosis, reporting intake over the preceding 12 months. Data on tumor-related factors, treatment and outcomes were obtained prospectively from medical records. Cox survival analyses were conducted after 52 deaths (median follow-up 6.1 years). All p values are for quadratic models. RESULTS: Mean age was 50.4¦9.8. 259 women had T1, 153 T2, and 22 T3 tumors; 146 were N1. 135 received adjuvant chemotherapy, 141 hormone therapy and 46 both. For all major energy sources Cox models identified significant curvilinear (quadratic) associations with OS, that is, OS was best for a mid-range quintile (Q) of daily intake and worse for higher and lower quintiles of intake. Significance persisted after multivariate adjustment for total energy intake, BMI, T and N stage and adjuvant therapy. For FAT (gm), the unadjusted hazard ratio (HR) was 3.6 in Q1 (lowest intake), 2.5 in Q2, 1.0 in Q3 (68.2-83.0 gm), 2.1 in Q4 and 2.5 in Q5, univariate p= 0.007, multivariate p=0.003. For PROTEIN (gm) the HR was lowest in Q4 (70.6-84.9 gm), univariate p=0.04, multivariate p=0.03. For ALCOHOL (drinks) the HR was lowest in Q4 (2.1-5.9 drinks), univariate p=0.004, multivariate p=0.008. For CARBOHYDRATES (% cal) the HR was lowest in Q3 (42.5-46.5 % cal), univariate p=0.001, multivariate p=0.001. The magnitude of HRs for protein, alcohol and carbohydrates was similar to those for fat. CONCLUSIONS: Our results suggest the association of major dietary sources of energy with OS is not linear: mid-range intake of each source is associated with the most favorable OS, extremes were associated with less favorable OS.

 


  Associated Presentation(s):

    

1. Major dietary sources of energy (fat, carbohydrates, protein, alcohol) and breast cancer (BC) survival: evidence for favorable levels of intake.

Meeting: 2002 ASCO Annual Meeting
Presenter: Pamela J. Goodwin, MD
Session: Breast Cancer (Poster Discussion)


  Other Abstracts in this Sub-Category:

    

1. Comparative value of SBR grade, hormonal receptors, KI 67, HER-2 and topo-isomerase II alpha (topo II alpha) status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Meeting: 2002 ASCO Annual Meeting   Abstract No: 123   First Author: Marc Wilt
Category: Breast Cancer - Adjuvant Therapy

    

2. Correlation between HER2 expression of breast cancer and response to neoadjuvant FAC chemotherapy

Meeting: 2002 ASCO Annual Meeting   Abstract No: 124   First Author: Fan Zhang
Category: Breast Cancer - Adjuvant Therapy

    

3. Quantitative image analysis of HER-2 protein expression by immunohistochemistry (IHC) improves the correlation with HER-2 gene amplification by fluorescence in situ hybridization (FISH): experience with 1002 cases.

Meeting: 2002 ASCO Annual Meeting   Abstract No: 128   First Author: Randy Judd
Category: Breast Cancer - Adjuvant Therapy

    

More...


  Abstracts by Pamela J Goodwin:

    

1. Major dietary sources of energy (fat, carbohydrates, protein, alcohol) and breast cancer (BC) survival: evidence for favorable levels of intake.

Meeting: 2002 ASCO Annual Meeting   Abstract No: 178   First Author: Pamela J Goodwin
Category: Breast Cancer - Adjuvant Therapy

    

2. Quality of life (QOL) and psychosocial support in women with metastatic breast cancer (MBC): results of a multicentre randomized trial.

Meeting: 2002 ASCO Annual Meeting   Abstract No: 1424   First Author: Louise Bordeleau
Category: Patient Management - Quality-of-Life Management

    

3. Economic Analysis of TAX 317: Docetaxel Vs. Best Supportive Care (BSC) for Second-Line Management of Advanced Non-Small Cell Lung Cancer (NSCLC).

Meeting: 2001 ASCO Annual Meeting   Abstract No: 1291   First Author: Natasha B. Leighl
Category: Lung Cancer - Non-Small-Cell Lung Cancer

    

More...


  Presentations by Pamela J Goodwin:

    

1. Diet, Exercise and Supplements: Guidelines for Cancer Survivors: Vitamin D

Meeting: 2009 ASCO Annual Meeting
Chair: Pamela Jean Goodwin, MD
Session: Diet, Exercise, and Cancer: Does the Evidence Support Lifestyle Modification as Part of Cancer Treatment? (Education Session)

    

2. The Role of Vitamin D in Breast Cancer Recurrence

Meeting: 2009 ASCO Annual Meeting
Speaker: Pamela Jean Goodwin, MD
Session: Vitamin D Supplementation: Does It Have a Role in Cancer Treatment and Prevention? (Education Session)

    

3. Welcome and Introductions

Meeting: 2009 ASCO Annual Meeting
Chair: Pamela Jean Goodwin, MD
Session: Diet, Exercise, and Cancer: Does the Evidence Support Lifestyle Modification as Part of Cancer Treatment? (Education Session)

    

More...


  Educational Book Manuscripts by Pamela J Goodwin:

    

No items found.




 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.